These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8841503)

  • 1. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
    Nikolić-Vukosavljević D; Vasiljević N; Branković-Magić M; Polić D
    Neoplasma; 1996; 43(3):163-9. PubMed ID: 8841503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual cycle and hormone receptor status in breast cancer patients.
    Atalay C; Kanliöz M; Altinok M
    Neoplasma; 2002; 49(4):278. PubMed ID: 12382029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of estrogen and progesterone receptors to the menstrual cycle and menopausal status at the time of breast surgery].
    Karbowski B; Jackisch C; Deppe B; Schneider HP
    Zentralbl Gynakol; 1999; 121(8):367-74. PubMed ID: 10486879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
    Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
    Mangia A; De Lena M; Barletta A; Marzullo F; Attolico M; Stea B; Petroni S; Labriola A; Cellamare G; Digiesi G; Altieri R; Schittulli F; Paradiso A
    J Exp Clin Cancer Res; 1998 Sep; 17(3):317-23. PubMed ID: 9894769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
    Saez S; Martin PM; Chouvet CD
    Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Receptor-binding capacity for estrogens and progesterone in the uterine cervix during the menstrual cycle and in the postmenopausal period].
    Kaiser R; Würz H; Steenken A; Piert M
    Geburtshilfe Frauenheilkd; 1988 Apr; 48(4):228-31. PubMed ID: 3378688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of estrogen and progesterone receptors in various phases of the menstrual cycle in breast cancer.
    Vasei M; Azarpira N; Talei A
    Arch Iran Med; 2006 Jul; 9(3):250-3. PubMed ID: 16859061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
    Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: a randomized study.
    Hallberg G; Persson I; Naessén T; Magnusson C
    Gynecol Endocrinol; 2008 Aug; 24(8):475-80. PubMed ID: 18850387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal status and cut off levels of steroid receptor ligand binding assays in breast cancer.
    Norgren A; Forsberg AH; Lindgren A; Sällström JF
    Anticancer Res; 1989; 9(1):173-6. PubMed ID: 2495752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on serum inhibin concentrations in women during menopausal transition].
    Zhang YW; Chen WL; Yu Q; Song YH; Zhou J; Zhang DY
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):98-101. PubMed ID: 12783698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.
    Gail MH; Fears TR; Hoover RN; Chandler DW; Donaldson JL; Hyer MB; Pee D; Ricker WV; Siiteri PK; Stanczyk FZ; Vaught JB; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):835-44. PubMed ID: 8896895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
    Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
    Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.